BlueLinx (BXC) announced that its Board of Directors has approved a new share repurchase authorization under which the Company may repurchase up to $50 million of its outstanding shares of common stock in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The new authorization will be funded through a combination of cash on hand and cash flow from operations. At the end of June 2025, the Company had $11.5 million remaining under the $100 million share repurchase program announced in October 2023, bringing the total current authorized availability for repurchase to $61.5 million.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BXC:
- BlueLinx reports Q2 adjusted EPS 70c, consensus $1.06
- BlueLinx says average daily sales volumes up slightly in Q3 vs Q2
- BXC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Snowflake initiated, Chipotle upgraded: Wall Street’s top analyst calls
- BlueLinx downgraded to Neutral from Buy at DA Davidson